Literature DB >> 24214623

T cell responses to drugs and drug metabolites.

C J Earnshaw1, T Pecaric-Petkovic, B K Park, D J Naisbitt.   

Abstract

Understanding the chemical mechanisms by which drugs and drug metabolites interact with cells of the immune system is pivotal to our knowledge of drug hypersensitivity as a whole.In this chapter, we will discuss the currently accepted mechanisms where there is scientific and clinical evidence to support the ways in which drugs and their metabolites interact with T cells. We will also discuss bioanalytical platforms, such as mass spectrometry, and in vitro test assays such as the lymphocyte transformation test that can be used to study drug hypersensitivity; the combination of such techniques can be used to relate the chemistry of drug antigen formation to immune function. Ab initio T cell priming assays are also discussed with respect to predicting the potential of a drug to cause hypersensitivity reactions in humans in relation to the chemistry of the drug and its ability to form haptens, antigens and immunogens in patients.

Entities:  

Mesh:

Year:  2014        PMID: 24214623     DOI: 10.1007/978-3-0348-0726-5_10

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  4 in total

1.  Recovery and assessment of leukocytes from LR Express filters.

Authors:  Abby K Wegehaupt; Ellen K Roufs; Cory R Hewitt; Marisela L Killian; Oxana Gorbatenko; Cynthia M Anderson; M Scott Killian
Journal:  Biologicals       Date:  2017-07-31       Impact factor: 1.856

Review 2.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

Review 3.  Hypersensitivity to non-β-lactam antibiotics.

Authors:  Hans F Merk; David R Bickers
Journal:  Allergol Select       Date:  2022-01-24

Review 4.  Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire?

Authors:  Rami Bechara; Alexia Feray; Marc Pallardy
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.